SPX4,026.12-1.14 -0.03%
DIA343.52+1.57 0.46%
IXIC11,226.36-58.96 -0.52%

Allarity Therapeutics Q3 EPS $(0.68) Down From $(0.17) YoY

Benzinga · 11/15/2022 16:02
Allarity Therapeutics (NASDAQ:ALLR) reported quarterly losses of $(0.68) per share. This is a 300 percent decrease over losses of $(0.17) per share from the same period last year.